Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.5%

3 terminated/withdrawn out of 119 trials

Success Rate

95.8%

+9.3% vs industry average

Late-Stage Pipeline

13%

15 trials in Phase 3/4

Results Transparency

13%

9 of 69 completed trials have results

Key Signals

19 recruiting9 with results

Enrollment Performance

Analytics

N/A

51(67.1%)

Phase 4

9(11.8%)

Phase 3

6(7.9%)

Phase 2

6(7.9%)

Early Phase 1

2(2.6%)

Phase 1

2(2.6%)

76Total

N/A(51)

Phase 4(9)

Phase 3(6)

Phase 2(6)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (119)

Showing 20 of 119 trials

NCT07368881Not ApplicableRecruiting

Fast Food Online Delivery Purchase Behaviour in the Presence and Absence of Price-based Incentives

Role: collaborator

NCT06711718Completed

Diabetes in Primary Care - Improving Classification

Role: collaborator

NCT06815081Recruiting

Capillary OGTT Study

Role: collaborator

NCT05315570Not ApplicableCompleted

Big Data for Quality of Life in Head and Neck Cancer

Role: collaborator

NCT06923241Not ApplicableCompleted

Nutri-score Labelling in a UK Restaurant Setting: a Randomised Control Trial

Role: collaborator

NCT06192719Recruiting

EULAT Eradicate GBC

Role: collaborator

NCT04936620Not ApplicableRecruiting

Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling

Role: collaborator

NCT06282055Recruiting

Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes

Role: collaborator

NCT06285110Completed

HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen

Role: collaborator

NCT05248919Not ApplicableEnrolling By Invitation

Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan

Role: collaborator

NCT07238049Enrolling By Invitation

REAl World Dementia OUTcomes: Observational Study

Role: collaborator

NCT06129916Not Yet Recruiting

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Role: collaborator

NCT06395129Recruiting

Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries

Role: collaborator

NCT05127057Not ApplicableCompleted

Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)

Role: lead

NCT04226248Phase 3Completed

CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)

Role: lead

NCT07125365Recruiting

UK Islet Autoantibody Registry

Role: collaborator

NCT03949764Phase 4Completed

The Kentucky Viral Hepatitis Treatment Study

Role: collaborator

NCT07093359Phase 3Recruiting

LINX vs Fundoplication

Role: collaborator

NCT06153459Not ApplicableRecruiting

Cord Clamping Among Neonates With Congenital Heart Disease

Role: collaborator

NCT06668168Not ApplicableRecruiting

The Causal Role of Ketone Bodies in Obesity-associated Disease Prevention - Combining Genetic Epidemiology With a Randomised Trial to Infer Causality

Role: collaborator